Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Maus anti-Human IgA1 Antikörper (PE)

ELISA Monoclonal B3506B4 IgG1 PE
Produktnummer ABIN376571
  • Target Alle IgA1 Produkte
    IgA1
    Reaktivität
    Human
    Wirt
    • 7
    • 2
    • 2
    Maus
    Klonalität
    • 9
    • 2
    Monoklonal
    Konjugat
    • 4
    • 3
    • 2
    • 1
    • 1
    PE
    Applikation
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    ELISA
    Spezifität
    Human IgA1 Fc, Mr 170 kDa
    Produktmerkmale
    Mouse Anti-Human IgA1-PE
    Aufreinigung
    Purified
    Immunogen
    Fc fragment of human IgA1 myeloma protein
    Klon
    B3506B4
    Isotyp
    IgG1
  • Applikationshinweise
    • Applications: ELISA - Quality tested , FLISA - Quality tested ELISPOT - Reported in literature , FC - Reported in literature , IHC-FS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , Multiplex - Reported in literature , Sep - Reported in literature , Depletion - Reported in literature
    • Working Dilutions: ELISA AP conjugate 1:1,000 - 1:4,000 HRP conjugate 1:1,000 - 1:4,000 BIOT conjugate 1:5,000 - 1:10,000 FLISA FITC and AF488 conjugates 1:200 - 1:400 PE and AF647 conjugates ≤ 1 g/mL
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.1 mg/mL
    Buffer
    0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Do not freeze!
    Protect conjugated products from light.

    Each reagent is stable for the period shown on the bottle label if stored as directed.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store at 2-8°C
  • Violari, Cotton, Kuhn, Schramm, Paximadis, Loubser, Shalekoff, Da Costa Dias, Otwombe, Liberty, McIntyre, Babiker, Gibb, Tiemessen: "A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation." in: Nature communications, Vol. 10, Issue 1, pp. 412, (2019) (PubMed).

  • Target
    IgA1
    Abstract
    IgA1 Produkte
Sie sind hier:
Kundenservice